Leukemia Secondary To Oncology Chemotherapy, CTCAE

Preferred Label : Leukemia Secondary To Oncology Chemotherapy, CTCAE;

NCIt related terms : Leukemia secondary to oncology chemotherapy;

Alternative definition : CTCAE 5.0: A disorder characterized by leukemia arising as a result of the mutagenic effect of chemotherapy agents.;

NCI Metathesaurus CUI : CL541919;

Détails

Origin ID

C143646;

UMLS CUI

C4553165;

Automatic exact mappings (from CISMeF team)
- Leukemia secondary to oncology chemotherapy [MedDRA LLT]
Semantic type(s)
- Finding [UMLS semantic type]
concept_is_in_subset
- CTCAE Adverse Events Version 5.0 Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
has_CTCAE_5_parent
- Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps), CTCAE [NCIt concept]
parent_is_CTCAE_5
- Grade 4 Leukemia Secondary To Oncology Chemotherapy, CTCAE [NCIt concept]
- Grade 5 Leukemia Secondary To Oncology Chemotherapy, CTCAE [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients